全文获取类型
收费全文 | 1176篇 |
免费 | 60篇 |
国内免费 | 147篇 |
专业分类
儿科学 | 58篇 |
妇产科学 | 6篇 |
基础医学 | 94篇 |
口腔科学 | 18篇 |
临床医学 | 167篇 |
内科学 | 316篇 |
皮肤病学 | 29篇 |
神经病学 | 37篇 |
特种医学 | 312篇 |
外科学 | 58篇 |
综合类 | 34篇 |
一般理论 | 1篇 |
预防医学 | 60篇 |
眼科学 | 13篇 |
药学 | 119篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 57篇 |
出版年
2023年 | 3篇 |
2022年 | 2篇 |
2021年 | 4篇 |
2020年 | 5篇 |
2019年 | 8篇 |
2018年 | 17篇 |
2017年 | 6篇 |
2016年 | 10篇 |
2015年 | 11篇 |
2014年 | 20篇 |
2013年 | 36篇 |
2012年 | 15篇 |
2011年 | 26篇 |
2010年 | 31篇 |
2009年 | 46篇 |
2008年 | 28篇 |
2007年 | 122篇 |
2006年 | 27篇 |
2005年 | 40篇 |
2004年 | 16篇 |
2003年 | 11篇 |
2002年 | 27篇 |
2001年 | 23篇 |
2000年 | 23篇 |
1999年 | 26篇 |
1998年 | 79篇 |
1997年 | 78篇 |
1996年 | 71篇 |
1995年 | 62篇 |
1994年 | 46篇 |
1993年 | 54篇 |
1992年 | 24篇 |
1991年 | 23篇 |
1990年 | 19篇 |
1989年 | 51篇 |
1988年 | 32篇 |
1987年 | 34篇 |
1986年 | 31篇 |
1985年 | 26篇 |
1984年 | 23篇 |
1983年 | 13篇 |
1982年 | 27篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1977年 | 16篇 |
1976年 | 28篇 |
1975年 | 13篇 |
1932年 | 2篇 |
排序方式: 共有1383条查询结果,搜索用时 718 毫秒
1.
2.
3.
Adverse reaction to intravenous gadoteridol 总被引:1,自引:0,他引:1
4.
5.
6.
Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. 总被引:3,自引:2,他引:1
下载免费PDF全文
![点击此处可从《Heart (British Cardiac Society)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
OBJECTIVES--To determine the effects of enoximone on mortality and quality of life in patients with severe end stage heart failure. DESIGN--A randomised, double blind, placebo controlled trial of the addition of enoximone to conventional treatment. Planned minimum follow up of one year. SETTING--District general hospitals and cardiological referral centres in the United Kingdom. PATIENTS--Planned 200 patients with severe, symptomatic heart failure despite treatment with diuretics and where appropriate and tolerated angiotensin converting enzyme inhibitors and digoxin. RESULTS--The study was ended early by the ethics committee after 151 patients had been recruited because of an excess mortality in the enoximone group: 27 deaths compared with 18 in the placebo group (P < 0.05). Quality of life measured with a disease specific questionnaire showed a clinically significant improvement at week 2 with a mean increase score of 0.48 in the enoximone treated patients compared with 0.14 in those receiving placebo (P = 0.0086). With the Nottingham health profile questionnaire the physical mobility score was improved after three months in the enoximone group, median 21.3 compared with 41.8 in the placebo group (P = 0.008). CONCLUSIONS--In patients with severe heart failure who remain incapacitated despite conventional treatment enoximone reduced survival but had a beneficial effect on the quality of life. Drugs that improve symptoms in severe end stage heart failure should not be discarded lightly. 相似文献
7.
Standard models for the analysis of repeated measurements assume a common response profile for all experimental units within a treatment group. However, in many applications this under-represents the nature of the response. There may be several distinct modes of response within a group (for example, responders versus non-responders to a given treatment), or there may be a set of distinct response profiles which are common to all the treatment groups. In these situations the effect of treatment can be characterized both by the shape of the fitted profiles and by estimating the proportion of cases who exhibit each particular response profile. This paper describes how such experiments may be analysed through the introduction of a latent variable into the standard model. Maximum likelihood estimation is straight-forward using the EM algorithm. Model choice requires some care, but good-fitting models can be identified via inspection of residuals and the use of empirical semi-variogram plots. Once the number of distinct profiles has been determined, treatment effects can be investigated using likelihood-ratio statistics. The approach is illustrated with a re-analysis of a dataset first described by Grizzle and Allen. 相似文献
8.
9.
10.
Intestinal schistosomiasis japonica: CT-pathologic correlation 总被引:1,自引:0,他引:1
Lee RC; Chiang JH; Chou YH; Rubesin SE; Wu HP; Jeng WC; Hsu CC; Tiu CM; Chang T 《Radiology》1994,193(2):539